CA
NZ
UK
AU
IND
US
A 1-for-22 reverse stock split, a Nasdaq compliance fight and aMarket Valueof only a few million dollars frame the current story at Genprex, Inc (NASDAQ: GNPX). The Austin-based gene-therapy developer has spent 2026 defending its listing while pushing cancer and diabetes programs forward. A …
Gossamer Bio, Inc (NASDAQ:GOSS) has become one of the more volatile names in the pulmonary-disease space after a pivotal trial stumble reshaped itsInvestmentstory in 2026. The stock now trades far below its former levels, and even modest dollar moves translate into large percentage swings …
A double-digit percentage drop grabs attention, but in Grapefruit USA, Inc. (OTC:GPFT) the more revealing figure is the price itself: a few ten-thousandths of a dollar. At that level, a move of a single tick can read as a 29% plunge while representing almost …
GlobeStar Therapeutics Corporation (OTC:GSTC) markets itself as a clinical-stage pharmaceutical company, but the more accurate description is a small, quiet OTC name whose flow of announcements has slowed to a trickle. The company's last widely circulated updates are more than a year old.
A single-session slide in a thinly traded nano-cap biotech rarely tells the full story, and CytoMed Therapeutics (NASDAQ: GDTC) is a clear example. The Singapore-based cell-therapy developer, whose shares eased about 8.7% to around $0.79, carries a marketCapitalizationof roughly $9 million, small enough that …
● GE HealthCare is one of the world's largest medical technology companies, spanning imaging such as CT, MRI and molecular imaging, along with ultrasound, patient care solutions and pharmaceutical diagnostics.
● The roughly 26% advance does not map to a single, clearly identifiable public catalyst disclosed on or around the trading day.
Global Medical Products Holdings, Inc. (OTC:GMDP) sits at the most obscure end of the public-market spectrum. Quoted at essentially a hundredth of a cent with aMarket Valueof only a few dozen dollars in the last closing session, GMDP is a nano-cap ticker with a …
Yubo International Biotech is a China-focused health and personal-care company built around endometrial stem-cell research, development and application. It markets consumer and wellness products under the VIVCELL brand, spanning respiratory, skincare, hair-care and beverage lines, and offers stem-cell testing and health-management consulting services. The …
Seres Therapeutics is a Nasdaq-listed clinical-stage company pioneering microbiome therapeutics, live bacterial consortia designed to treat disease by modulating the gut. Its former commercial product, VOWST, was divested to Nestlé Health Science, and Seres now centers its future on SER-155, a cultivated microbiome candidate. …
Please wait processing your request...